Shanghai, China – 7 November, 2014 – MicroPort NeuroTech (Shanghai) ("MicroPort NeuroTech") attended the 14th Oriental Conference of Interventional Neuroradiology ("OCIN") that was held from October 31 to November 2 in Shanghai, to promote our neurovascular devices.
During the conference, MicroPort NeuroTech were present with a booth that focused on our products such as WILLIS® Intracranial Stent Graft System ("WILLIS®") and Tubridge® Vascular Reconstruction Device ("Tubridge®"). We also arranged a variety of activities, including WILLIS® surgery simulation and live broadcasted surgery of WILLIS®, to enable participants to gain hands-on experience and in-depth knowledge on the product. Meanwhile, Professor Qinghai Huang with Shanghai-based Changhai Hospital and Professor Donglei Song from Shanghai Neuromedical Center were invited to present in details the clinical applications and efficacy of WILLIS® and Tubridge® with thorough and reliable clinical data.
In OCIN, WILLIS® was highly recognized by healthcare professionals in attendance. "As the first neurovascular stent graft in the world, WILLIS® shows our (China's) determination for innovation," said Professor Jianmin Liu from Changhai Hospital. Also, Professor Weijian Jiang of the Second Artillery General Hospital of Chinese People's Liberation Army expressed his praise on WILLIS®'s better-than-expected performances in some difficult cases.
To further optimize our devices, MicroPort NeuroTech later on invited healthcare professionals who attended OCIN to visit our product showrooms and manufacturing plants, and organized a face-to-face discussion with them on how to improve the future devices in terms of R&D, design and production. "We hope to continue working with doctors to get ideas and inspirations to develop more high-quality products so as to better serve them and patients," said Bo Peng, Chief Marketing Officer of MicroPort Scientific Corporation.